Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215884 · ClinicalTrials.gov registry record · Phase 1
Dopamine and Sensorimotor Function in Stuttering
A Phase 1 study of Stuttering, Adult, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07215884: Recruiting Phase 1 study of Stuttering, Adult, sponsored by University of California, San Francisco.
NCT07215884 is a Phase 1 study of Stuttering, Adult that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants, below the 661-participant average among 5 other Stuttering, Adult trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215884, a Phase 1 study of Stuttering, Adult, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.
Primary Outcome
Pre-speech auditory modulation (PSAM) is a measure of auditory cortical activity (as collect via magnetoencephalography) in response to a speaking and and matching silent reading task.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Aripiprazole 10 MG
Study Locations (1)
California
- Biomagentic Imaging Lab - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 1 |
What NCT07215884 shows while recruiting
NCT07215884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 661-participant average among 5 other Stuttering, Adult trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Stuttering, Adult appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07215884 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07215884 about?
NCT07215884 is a clinical study titled "Dopamine and Sensorimotor Function in Stuttering". This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.
What is the current status of trial NCT07215884?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2025-09-30. Estimated completion is 2026-06-30.
What conditions does trial NCT07215884 study?
This clinical trial studies the following conditions: Stuttering, Adult.
What interventions are being tested in trial NCT07215884?
The interventions under investigation include: Placebo (DRUG), Aripiprazole 10 MG (DRUG).
Who is sponsoring clinical trial NCT07215884?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215884 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stuttering, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Using Transcranial Magnetic Stimulation to Treat Stuttering
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Stuttering
RECRUITING · NA
-
Exploring the Nature, Assessment and Treatment of Stuttering
RECRUITING · NA
-
Information Processing Biases in Adults Who Stutter
RECRUITING · NA
-
Speech Processing in Stuttering
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI